Clinical Trials Browser

Phase 2/3 × Interventional × Hepatitis B × Clear all

NCT04044651 2020-01-09

Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection

Phase 2/3 Withdrawn

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular